Literature DB >> 18363309

High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study.

Hal A Droogleever Fortuyn1, Sofie Swinkels, Jan Buitelaar, Wily O Renier, Joop W Furer, Cees A Rijnders, Paul P Hodiamont, Sabastiaan Overeem.   

Abstract

STUDY
OBJECTIVES: To study the prevalence of and symptoms of eating disorders in patients with narcolepsy.
DESIGN: We performed a case-control study comparing symptoms of eating disorders in patients with narcolepsy versus healthy population controls, using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN 2.1). To study whether an increased body mass index (BMI) could be responsible for symptoms of an eating disorder, we also compared patients with BMI-matched controls, using the SCAN as well as the Eating Disorder Examination-Questionnaire.
SETTING: University hospital. PATIENTS AND PARTICIPANTS: Patients with narcolepsy/cataplexy (n = 60) were recruited from specialized sleep centers. Healthy controls (n = 120) were drawn from a population study previously performed in the Netherlands. Separately, 32 BMI-matched controls were recruited.
INTERVENTIONS: N/A. MEASUREMENTS AND
RESULTS: In total, 23.3% of the patients fulfilled the criteria for a clinical eating disorder, as opposed to none of the control subjects. Most of these were classified as Eating Disorder-Not Otherwise Specified, with an incomplete form of binge eating disorder. On the symptom level, half of the patients reported a persistent craving for food, as well as binge eating. Twenty-five percent of patients even reported binging twice a week or more often. When compared with BMI-matched controls, the significant increases persisted in symptoms of eating disorders among patients with narcolepsy. Except for a higher level of interference in daily activities due to eating problems in patients using antidepressants, medication use did not influence our findings.
CONCLUSIONS: The majority of patients with narcolepsy experience a number of symptoms of eating disorders, with an irresistible craving for food and binge eating as the most prominent features. Eating disorder symptomatology interfered with daily activities. These findings justify more attention for eating disorders in the treatment of patients with narcolepsy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363309      PMCID: PMC2276738          DOI: 10.1093/sleep/31.3.335

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  40 in total

1.  Orexinergic innervation of POMC-containing neurons in the rat arcuate nucleus.

Authors:  J L Guan; T Saotome; Q P Wang; H Funahashi; T Hori; S Tanaka; S Shioda
Journal:  Neuroreport       Date:  2001-03-05       Impact factor: 1.837

2.  Reliability of the Eating Disorder Examination-Questionnaire in patients with binge eating disorder.

Authors:  Deborah L Reas; Carlos M Grilo; Robin M Masheb
Journal:  Behav Res Ther       Date:  2006-01

3.  The prevalence of eating disorders not otherwise specified.

Authors:  Paulo P P Machado; Barbara C Machado; Sónia Gonçalves; Hans W Hoek
Journal:  Int J Eat Disord       Date:  2007-04       Impact factor: 4.861

4.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

5.  The validity of the eating disorder examination and its subscales.

Authors:  Z Cooper; P J Cooper; C G Fairburn
Journal:  Br J Psychiatry       Date:  1989-06       Impact factor: 9.319

6.  Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans.

Authors:  S W Kok; A E Meinders; S Overeem; G J Lammers; F Roelfsema; M Frölich; H Pijl
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

7.  Psychiatric disorders in a Dutch Health Area: a repeated cross-sectional survey.

Authors:  P P G Hodiamont; C A Th Rijnders; J Mulder; J W Furer
Journal:  J Affect Disord       Date:  2005-01       Impact factor: 4.839

8.  Binge eating as a major phenotype of melanocortin 4 receptor gene mutations.

Authors:  Ruth Branson; Natascha Potoczna; John G Kral; Klaus-Ulrich Lentes; Margret R Hoehe; Fritz F Horber
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

Review 9.  Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.

Authors:  Sebastiaan Overeem; Thomas E Scammell; Gert Jan Lammers
Journal:  Curr Opin Neurol       Date:  2002-12       Impact factor: 5.710

10.  Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.

Authors:  Lena Brundin; Maria Björkqvist; Asa Petersén; Lil Träskman-Bendz
Journal:  Eur Neuropsychopharmacol       Date:  2007-03-07       Impact factor: 4.600

View more
  23 in total

1.  [Narcolepsy].

Authors:  G Mayer
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

2.  Reward-seeking behavior in human narcolepsy.

Authors:  Alexandra Dimitrova; Rolf Fronczek; Janneke Van der Ploeg; Thomas Scammell; Shiva Gautam; Alvaro Pascual-Leone; Gert Jan Lammers
Journal:  J Clin Sleep Med       Date:  2011-06-15       Impact factor: 4.062

Review 3.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

4.  Narcolepsy with cataplexy associated with nocturnal compulsive behaviors: a case-control study.

Authors:  Vincenzo Palaia; Francesca Poli; Fabio Pizza; Elena Antelmi; Christian Franceschini; Keivan Kaveh Moghadam; Frederica Provini; Uberto Pagotto; Pasquale Montagna; Carlos H Schenck; Emmanuel Mignot; Giuseppe Plazzi
Journal:  Sleep       Date:  2011-10-01       Impact factor: 5.849

Review 5.  Medical comorbidity of binge eating disorder.

Authors:  Pablo Olguin; Manuel Fuentes; Guillermo Gabler; Anna I Guerdjikova; Paul E Keck; Susan L McElroy
Journal:  Eat Weight Disord       Date:  2016-08-23       Impact factor: 4.652

6.  Increased mortality in narcolepsy.

Authors:  Maurice M Ohayon; Jed Black; Chinglin Lai; Mark Eller; Diane Guinta; Arun Bhattacharyya
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

7.  Aberrant Food Choices after Satiation in Human Orexin-Deficient Narcolepsy Type 1.

Authors:  Ruth Janke van Holst; Lisa van der Cruijsen; Petra van Mierlo; Gert Jan Lammers; Roshan Cools; Sebastiaan Overeem; Esther Aarts
Journal:  Sleep       Date:  2016-11-01       Impact factor: 5.849

8.  Body mass index-independent metabolic alterations in narcolepsy with cataplexy.

Authors:  Francesca Poli; Giuseppe Plazzi; Guido Di Dalmazi; Danilo Ribichini; Valentina Vicennati; Fabio Pizza; Emmanuel Mignot; Pasquale Montagna; Renato Pasquali; Uberto Pagotto
Journal:  Sleep       Date:  2009-11       Impact factor: 5.849

9.  Reactivation of hyperglycemia-induced hypocretin (HCRT) gene silencing by N-acetyl-d-mannosamine in the orexin neurons derived from human iPS cells.

Authors:  Koji Hayakawa; Yasuharu Sakamoto; Osamu Kanie; Atsuko Ohtake; Shusaku Daikoku; Yukishige Ito; Kunio Shiota
Journal:  Epigenetics       Date:  2017-11-24       Impact factor: 4.528

10.  Plasma total ghrelin and leptin levels in human narcolepsy and matched healthy controls: basal concentrations and response to sodium oxybate.

Authors:  Claire E H M Donjacour; Daniel Pardi; N Ahmad Aziz; Marijke Frölich; Ferdinand Roelfsema; Sebastiaan Overeem; Hanno Pijl; Gert Jan Lammers
Journal:  J Clin Sleep Med       Date:  2013-08-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.